Home > Offer to Sell > Pharmaceuticals and Biochemicals > Antibiotic and antimicrobial agents > Rifampicin
Rifampicin
Inquiry
| Post Date: | Jun 15,2015 |
| Expiry Date: | Jun 14,2016 |
| Detailed Description: |
Cas No. :13292-46-1
Appearance
Red to orange solid Complies Assay USP32 97.75% |
| CAS Registry Number: | 13292-46-1 |
| Synonyms: | ;3-(((4-Methyl-1-piperazinyl)imino)-methyl)rifamycin;Abrifam;Dipicin;Eremfat;R/AMP;RIF;Rifa;Rifadin;Rifadin I.V.;Rifaldin;rifaldazine;Rifamate;Rifamicin AMP;Rifampin;Rifaprodin;Rifater;Rifobac;Rifoldin;Riforal;Rimactan;Rimycin;Rifamycin SV Sodium;Rifandin;(2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-{(E)-[(4-methylpiperazin-1-yl)imino]methyl}-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate; |
| Molecular Formula: | C43H58N4O12 |
| Molecular Weight: | 822.9402 |
| Molecular Structure: | 
|
| Hazard Symbols: |  Xn:Harmful; |
| Risk Codes: | R22:; R36/37/38:; |
| Safety Description: | S26:; S36:; |
| Company: | Lanospharma Laboratories Co.,Ltd [ China ] |
| Contact: | Peter Wen |
| Tel: | +86-151 8282 8191 |
| Fax: | +86-23-63245915 |
| Email: | sales@lanospharma.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
